Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
1,418
Views
34
CrossRef citations to date
0
Altmetric
Reviews

Natural products in diabetes research: quantitative literature analysis

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Pages 5813-5827 | Received 03 Jun 2020, Accepted 28 Aug 2020, Published online: 07 Oct 2020

References

  • Alam F, Islam MA, Kamal MA, Gan SH. 2018. Updates on managing type 2 diabetes mellitus with natural products: towards antidiabetic drug development. Curr Med Chem. 25(39):5395–5431.
  • Alberti KGMM, Zimmet PZ. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 15(7):539–553.
  • Andrade-Cetto A, Heinrich M. 2005. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J Ethnopharmacol. 99(3):325–348.
  • Belwal T, Bisht A, Devkota HP, Ullah H, Khan H, Pandey A, Bhatt ID, Echeverría J. 2020. Phytopharmacology and clinical updates of Berberis species against diabetes and other metabolic diseases. Front Pharmacol. 11:41.
  • Bhatt JK, Thomas S, Nanjan MJ. 2012. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 32(7):537–541.
  • Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, et al. 2011. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 106(3):383–389.
  • Choudhury H, Pandey M, Hua CK, Mun CS, Jing JK, Kong L, Ern LY, Ashraf NA, Kit SW, Yee TS, et al. 2018. An update on natural compounds in the remedy of diabetes mellitus: a systematic review. J Tradit Complement Med. 8(3):361–376.
  • Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. 2012. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 35(11):2121–2127.
  • Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. 2014. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 25(2):144–150.
  • Daliu P, Annunziata G, Tenore GC, Santini A. 2020. Abscisic acid identification in Okra, Abelmoschus esculentus L. (Moench): perspective nutraceutical use for the treatment of diabetes. Nat Prod Res. 34(1):3–9.
  • Dei Cas M, Ghidoni R. 2019. Dietary curcumin: correlation between bioavailability and health potential. Nutrients. 11(9):2147.
  • Dias TR, Alves MG, Casal S, Oliveira PF, Silva BM. 2017. Promising potential of dietary (poly)phenolic compounds in the prevention and treatment of diabetes mellitus. Curr Med Chem. 24(4):334–354.
  • Dubey P, Mishra S. 2017. A review on: diabetes and okra (Abelmoschus esculentus). J Med Plants Stud. 5(3):23–26.
  • Durazzo A, Lucarini M, Novellino E, Souto EB, Daliu P, Santini A. 2019. Abelmoschus esculentus (L.): bioactive components’ beneficial properties—focused on antidiabetic role—for sustainable health applications. Molecules. 24(1):38.
  • Gong X, Ji M, Xu J, Zhang C, Li M. 2019. Hypoglycemic effects of bioactive ingredients from medicine food homology and medicinal health food species used in China. Crit Rev Food Sci Nutr. 60(14):2303–2326.
  • Gutiérrez RMP, Mitchell S, Solis RV. 2008. Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 117(1):1–27.
  • Kowluru RA, Kanwar M. 2007. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab. 4(1):8.
  • Kwon Y-II, Vattem DA, Shetty K. 2006. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac J Clin Nutr. 15(1):107–118.
  • Li A-N, Li S, Zhang Y-J, Xu X-R, Chen Y-M, Li H-B. 2014. Resources and biological activities of natural polyphenols. Nutrients. 6(12):6020–6047.
  • Lv J, Yu C, Guo Y, Bian Z, Yang L, Chen Y, Hu X, Hou W, Chen J, Chen Z, et al. 2017. Adherence to a healthy lifestyle and the risk of type 2 diabetes in Chinese adults. Int J Epidemiol. 46(5):1410–1420.,
  • Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al. 2007. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 450(7170):712–716.
  • Naik SR, Barbosa Filho JM, Dhuley JN, Deshmukh V. 1991. Probable mechanism of hypoglycemic activity of bassic acid, a natural product isolated from Bumelia sartorum. J Ethnopharmacol. 33(1–2):37–44.
  • Neag MA, Mocan A, Echeverría J, Pop RM, Bocsan CI, Crişan G, Buzoianu AD. 2018. Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 9:557.
  • Panahi Y, Khalili N, Sahebi E, Namazi S, Karimian MS, Majeed M, Sahebkar A. 2017. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology. 25(1):25–31.
  • Pandey KB, Rizvi SI. 2009. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2(5):270–278.
  • Pepato MT, Keller E, Baviera AM, Kettelhut IC, Vendramini RC, Brunetti IL. 2002. Anti-diabetic activity of Bauhinia forficata decoction in streptozotocin-diabetic rats. J Ethnopharmacol. 81(2):191–197.
  • Ríos JL, Francini F, Schinella GR. 2015. Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 81(12–13):975–994.
  • Salehi B, Ata A, Anil Kumar NV, Sharopov F, Ramírez-Alarcón K, Ruiz-Ortega A, Abdulmajid Ayatollahi S, Valere Tsouh Fokou P, Kobarfard F, Amiruddin Zakaria Z, et al. 2019. Antidiabetic potential of medicinal plants and their active components. Biomolecules. 9(10):551.
  • Sathasivampillai SV, Rajamanoharan PR, Munday M, Heinrich M. 2017. Plants used to treat diabetes in Sri Lankan Siddha Medicine – an ethnopharmacological review of historical and modern sources. J Ethnopharmacol. 198:531–599.
  • Shapiro K, Gong WC. 2002. Natural products used for diabetes. J Am Pharm Assoc. 42(2):217–226.
  • Sidhu GS, Mani H, Gaddipati JP, Singh AK, Seth P, Banaudha KK, Patnaik GK, Maheshwari RK. 1999. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen. 7(5):362–374.
  • Souto EB, Souto SB, Campos JR, Severino P, Pashirova TN, Zakharova LY, Silva AM, Durazzo A, Lucarini M, Izzo AA, et al. 2019. Nanoparticle delivery systems in the treatment of diabetes complications. Molecules. 24(23):4209.
  • Souto SB, Souto EB, Braga DC, Medina JL. 2011. Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM). Eur J Clin Pharmacol. 67(7):653–661.
  • Tiwari AK, Rao JM. 2002. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr Sci. 83:30–38.
  • Usharani P, Mateen A, Naidu M, Raju Y, Chandra N. 2008. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus. Drugs R&D. 9(4):243–250.
  • Van Eck NJ, Waltman L. 2010. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 84(2):523–538.
  • Van Eck NJ, Waltman L. 2011. Text mining and visualization using VOSviewer. ISSI Newslett. 7:50–54.
  • Van Eck NJ, Waltman L, van Raan AF, Klautz RJ, Peul WC. 2013. Citation analysis may severely underestimate the impact of clinical research as compared to basic research. PLoS One. 8(4):e62395.
  • Vieira R, Souto SB, Sánchez-López E, López Machado A, Severino P, Jose S, Santini A, Fortuna A, García ML, Silva AM. 2019. Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—review of classical and new compounds: part-I. Pharmaceuticals. 12(4):152.
  • Vieira R, Souto SB, Sánchez-López E, López Machado A, Severino P, Jose S, Santini A, Silva AM, Fortuna A, García ML. 2019. Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—strategies for in vivo administration: part-II. J Clin Med. 8(9):1332.
  • Wahner-Roedler DL, Vincent A, Elkin PL, Loehrer LL, Cha SS, Bauer BA. 2006. Physicians’ attitudes toward complementary and alternative medicine and their knowledge of specific therapies: a survey at an academic medical center. Evid Based Complement Alternat Med. 3(4):495–501.
  • Waltman L, Van Eck NJ, Noyons EC. 2010. A unified approach to mapping and clustering of bibliometric networks. J Informetrics. 4(4):629–635.
  • Wang L, Waltenberger B, Pferschy-Wenzig E-M, Blunder M, Liu X, Malainer C, Blazevic T, Schwaiger S, Rollinger JM, Heiss EH, et al. 2014. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol. 92(1):73–89.
  • Weisberg SP, Leibel R, Tortoriello DV. 2008. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology. 149(7):3549–3558.
  • Wong AY-T, Chan AW-K. 2014. Myriad and its implications for patent protection of isolated natural products in the United States. Chin Med. 9(1):17.
  • World Health Organization. 2016. Global report on diabetes. Geneva: World Health Organization.
  • Yeung AWK, Aggarwal BB, Barreca D, Battino M, Belwal T, Horbańczuk OK, Berindan-Neagoe I, Bishayee A, Daglia M, Devkota HP, et al. 2018. Dietary natural products and their potential to influence health and disease including animal model studies. Anim Sci Pap Reps. 36(4):345–358.
  • Yeung AWK, Aggarwal BB, Orhan IE, Horbanczuk OK, Barreca D, Battino M, Belwal T, Bishayee A, Daglia M, Devkota HP, et al. 2019. Resveratrol, a popular dietary supplement for human and animal health: quantitative research literature analysis – a review. Anim Sci Pap Rep. 37:103–118.
  • Yeung AWK, El-Demerdash A, Berindan-Neagoe I, Atanasov AG, Ho Y-S. 2018. Molecular responses of cancers by natural products: modifications of autophagy revealed by literature analysis. Crit Rev Oncog. 23(5–6):347–370.
  • Yeung AWK, Heinrich M, Atanasov AG. 2018. Ethnopharmacology – a bibliometric analysis of a field of research meandering between medicine and food science? Front Pharmacol. 9:215.
  • Yeung AWK, Horbańczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall’Acqua S, Gan R-Y, et al. 2019. Curcumin: total-scale analysis of the scientific literature. Molecules. 24(7):1393.
  • Yeung AWK, Orhan IE, Aggarwal BB, Battino M, Belwal T, Bishayee A, Daglia M, Devkota HP, El-Demerdash A, Balacheva AA, et al. 2020. Berberine, a popular dietary supplement for human and animal health: quantitative research literature analysis–a review. Anim Sci Pap Rep. 38(1):5–19.
  • Yeung AWK, Tzvetkov NT, El-Tawil OS, Bungǎu SG, Abdel-Daim MM, Atanasov AG. 2019. Antioxidants: scientific literature landscape analysis. Oxid Med Cell Longev. 2019:8278454.
  • Zengin G, Sarikurkcu C, Aktumsek A, Ceylan R, Ceylan O. 2014. A comprehensive study on phytochemical characterization of Haplophyllum myrtifolium Boiss. endemic to Turkey and its inhibitory potential against key enzymes involved in Alzheimer, skin diseases and type II diabetes. Ind Crops Prod. 53:244–251.
  • Zimmet P, Alberti KG, Magliano DJ, Bennett PH. 2016. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 12(10):616–622.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.